In addition, CIGB 814, an APL from a CD4+ T cell epitope of human Hsp60, an auto-antigen involved in the pathogenesis of RA, has been tested in 20 patients with moderated active RA in an open-label trial. Here, CD4 is linked to rheumatoid arthritis.